NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transderma...
NexGel Postpones 2026 Annual Stockholder Meeting for Votes
NexGel postpones annual shareholder meeting to July 31 from July 10
NexGel director Scott Henry resigns, stepping down as audit committee chair
Nexgel CEO Adam R. Levy sells 11,000 common shares worth $6,534.1
NexGel begins using new investor presentation under Regulation FD
Pre-market hot trades in US stocks: Exyn Tech up 13.45% in pre-market; Nexgel down 10.05% in pre-market